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Plasmablastic lymphoma (PBL) is a highly aggressive variant of diffuse large B-cell lymphoma and is
usually treated by chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone
(CHOP) or CHOP-like regimens. However, elderly patients tend to have difﬁculty with the chemotherapy.
We successfully treated an HIV-negative elderly PBL patient with surgery alone. An 87-year-old Japanese
man was referred to our hospital because of gingival swelling of the left maxilla. After several exami-
nations, a multilobular 3-cm tumor of the left maxilla and lymph node swelling on the left side of the
neck were revealed. The patient was HIV negative and human T-cell leukemia virus negative. He was
diagnosed with PBL, or undifferentiated carcinoma/sarcoma, and we performed surgical therapy, radical
neck dissection, and a partial maxillectomy. The surgical margin of the resected specimen was negative
for tumor cells, and 6 of 27 lymph nodes contained tumor cells. Histologically, the tumor consisted of
basophilic large cells with deviated nuclei. Together with the immunohistochemical ﬁndings, the ﬁnal
diagnosis was PBL. The patient and his family did not agree to chemotherapy. Nineteen months after
surgery, he is ﬁne and no signs of recurrence were observed. Surgery-only therapy may be a reasonable
alternative for elderly PBL patients.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Plasmablastic lymphoma (PBL) is a highly aggressive variant of
diffuse large B-cell lymphoma initially described in the oral cavity
of HIV-positive patients [1]. Untreated patients with PBL have a
median survival of 3 months [2]. Even with chemotherapy with
cyclophosphamide, doxorubicin, vincristine, and prednisone
(CHOP) or CHOP-like regimens, the prognosis of HIV-negative
patients was poor with a median overall survival of 9 months [2].
HIV-negative PBL patients tend to be elderly; therefore, they are
more at risk and ﬁnd it difﬁcult to receive chemotherapy. Here, we
report the successful treatment of an HIV-negative elderly PBL
patient with surgery.llofacial Surgery, Division of
y of Dental Science, Kyushu
582, Japan. Tel.: þ81-92-642-
.ac.jp (T. Yamada).
Inc. This is an open access article u2. Presentation of case
An 87-year-old Japanese man was referred to our hospital in
2013 because of gingival swelling of the left maxilla. His medical
history included hypertension, angina pectoris, hyperuricemia, and
dyslipidemia, and he received regular medical checkups. On phys-
ical examination, the gingiva of the upper ﬁrst and second molar
region was swollen with several ﬁrm, hemisphere-shaped masses.
The size of the lesion was 3 cm, with a smooth and reddish surface
(Figure 1). His peripheral blood count and biochemical analysis
were within normal ranges. The patient was HIV negative and
human T-cell leukemia virus negative. A panoramic radiograph
showed that the left ﬁrst and second molars were diversed and the
surrounding bone was resorbed. Computed tomography and mag-
netic resonance imaging revealed a homogeneously enhancedmass
around the left ﬁrst and second molars (Figure 2). In positron
emission tomography images, although there were areas of ﬂuo-
rodeoxyglucose uptake in the left maxilla and in lymph nodes on
the left side of the neck, no other lesions were detected (Figure 3).
An incisional biopsy revealed round-shaped tumor cells with atypiander the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Intraoral picture of gingival swelling. The gingiva of the upper molar region
was swollen with several ﬁrm, hemisphere-shaped masses covered with smooth and
reddish mucosa.
Figure 2. Magnetic resonance images with enhanced contrast. Magnetic resonance
imaging revealed a homogeneously enhanced mass around the left ﬁrst and second
molars (white arrows).
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nohistochemically, the tumor cells were positive for CD138 and
focally positive for CD3, CD30, leucocyte common antigen, and
epithelial membrane antigens (EMA) but negative for AE1/AE3, S-
100, melan A, E-cadherin, k, l, ALK, CD4, CD8, CD5, CD20, CD45RO,
and CD79a (Figure 4). The patient was diagnosed with PBL,
anaplastic plasmacytoma, or undifferentiated carcinoma/sarcoma.
If the tumor is PBL, there is no reliable chemotherapy regimen, and
because of the age of the patient, there is a high risk ofFigure 3. Positron emission tomography-computed tomography imaging with ﬂuorodeoxygl
maxilla. (B) Neck: lymph nodes with hypermetabolism are observed in the left upper neck. (Cchemotherapy in any event. Furthermore, the lesion was localized
to the left side of the neck and maxilla. Therefore, we performed
surgical therapy ﬁrst. Radical neck dissection and partial max-
illectomy were performed under general anesthesia (Figure 5). The
surgical margin of the resected specimen was negative for tumorucose. (A) Maxilla: a hypermetabolic gourd-shaped mass is observed in the left posterior
) Body: no hyper metabolic lesions are observed except in the left maxilla and neck.
Figure 4. Histologic and immunohistochemical features of biopsy specimens. (A) HE 100. (B) HE 400. (C) CD138 400. (D) EMA 400.
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tumors consisted of basophilic large cells with deviated nuclei.
Immunohistochemically, the tumor cells were positive for CD38,
CD138, MUM1, and EBER-1 (in situ hybridization) and focally pos-
itive for CD30, and EMA (Figure 6). However, the tumor cells were
negative for AE1/AE3, CAM5.2, Ber-EP4, S-100, melan A, E-cadherin,
desmin, c-kit, PLAP, vimentin, k, l, IgG, IgA, ALK, leucocyte common
antigen, granzyme B, CD3, CD4, CD5, CD8, CD15, CD20, CD45RO,
CD68, CD79a, and CD99. The ﬁnal diagnosis was PBL. The patient
and his family did not agree to chemotherapy, and observationFigure 5. Surgical specimen. (A) Resected maxilla with dental prosthcontinued for 19 months with no additional chemotherapy. The
patient is ﬁne, and no signs of recurrence were observed.
3. Discussion
PBL is an aggressive variant of diffuse large B-cell lymphoma
with a poor prognosis. PBL consists of large neoplastic cells such as
plasmablasts or B immunoblasts [3].
Originally, PBL was reported as an intraoral tumor arising in an
HIV-positive patient [1], and it accounts for 2.6% of HIV-relatedetic metal. (B) Dissected lymph nodes from surgical specimen.
Figure 6. Immunohistochemical features of surgical specimens. (A) CD30 400. (B) MUM1 400. (C) CD38 400. (D) EBER (in situ hybridization) 400.
Table 1
Differential diagnosis of the phenotype for plasmablastic lymphoma vs other tumors.
Phenotype Poorly
differentiated
carcinoma
Malignant
melanoma
PBL Immunoblastic
lymphoma
Common
DLBCL
BL Plasmacytoma Anaplastic/
plasmablastic
plasmacytoma
Present case
Biopsy Surgical
specimen
Neoplastic cell
size
Large Large Large Large Large Intermediate Intermediate Large Large Large
Ckpan þ         
EMA þ  Variable      þ,
Focal
þ, Focal
HMB-45  þ       NA NA
Melan A  þ       NA NA
S-100  þ        
CD45   Variable þ þ þ   þ,
Focal

Bcl-6    þ þ þ   NA NA
CD20   / þ þ þ    
CD138   þ    þ þ þ þ
VS38c   þ  /  þ þ NA NA
k, l Light
chain
  Variable þ   þ þ NA 
Ig heavy chain   G M G, M, and/or
D
M G, A, M, or D G, A, M, or D NA 
MUM1   þ    þ þ NA þ
PAX-5    þ þ    NA NA
PRDM1/
BLIMP1
  þ    þ þ NA NA
EBV   þ   þ   NA þ
HHV-8   Variable      NA NA
Bcl-6 ¼ B-cell leukemia 6; BL ¼ Burkitt lymphoma; CD ¼ cluster of differentiation; CKpan ¼ broad-spectrum cytokeratin; DLBCL ¼ diffuse large B-cell lymphoma;
EMA ¼ epithelial membrane antigen; HHV ¼ human herpesvirus 8; HMB-45 ¼ melanoma antibody; MUM1 ¼ multiple melanoma oncogene-1 protein; NA ¼ not available;
PAX-5 ¼ B-cell speciﬁc activator protein; PBL ¼ plasmablastic lymphoma; PRDM1/BLIMP1 ¼ a fundamental regulator protein of terminal B-cell differentiation.
þ indicates expression of the antigen in a majority of cells,  indicates absence of antigen expression, and  indicates weak antigen expression.
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or HIV-negative cases, such as in posttransplantation or elderly
patients, were reported [5-8].HIV-related PBL is thought to be associated with Epstein-Barr
virus (EBV) and human herpesvirus 8 because of the compromised
conditions caused by immunodeﬁciency [9,10].
Table 2
PBL of the oral cavity in HIV-negative patients.
Case no. Author Year Gender Age (y) Location Stage Immunosuppression EBV Treatment Prognosis (mo)
1 Delecluse HJ et al. [1] 1997 F 75 Gingiva IAE No NA RT DOD (3)
2 Robak T et al. [17] 2001 F 57 Mandible (rt) IV CLL  CT DOD (6)
3 Lin F et al. [18] 2004 M 82 Maxilla (rt), LN III No þ CT Alive (6)
4 Colomo L et al. [19] 2004 M 56 Oral mucosa NA No  NA NA
5 Colomo L et al. [19] 2004 F 50 Oral mucosa, sinus, BM IV Kidney transplant þ NA DOD (19)
6 Barroso Duarte EC et al.[20] 2005 M 60 Upper lip, palate (rt) IE No þ CT þ RT Alive (23)
7 Scheper MA et al. [21] 2005 M 49 Mandibular mucosa (rt) IIE No þ NA NA
8 Tzankov A et al. [22] 2005 M 63 Mandibular gingiva (rt) IE No þ NA NA
9 Lee OJ et al. [23] 2006 M 66 Mandibular mucosa (lt) IE No  CT þ RT DOD (8)
10 Borenstein J et al. [5] 2007 M 46 Palate IE Cardiac transplant þ NA NA
11 Kim JE et al. [4] 2009 M 66 Oral cavity IA No  CT þ RT DOD (8)
12 Montes-Moreno et al. [24] 2010 F 81 Oral cavity, sinus II No  CT NA
13 Montes-Moreno et al. [24] 2010 M 82 Oral cavity NA No þ NA NA
14 Gogia A et al. [25] 2010 F 2 Mandible (ant) IE No NA CT DOD (NA)
15 Rao DD et al. [26] 2010 M 65 Mandible (ant) IE No NA CT þ RT Alive (12)
16 Rao DD et al. [26] 2010 M 70 Mandibular gingiva (lt) IE No NA CT þ RT Alive (6)
17 Hansra D et al. [13] 2010 F 48 Mandible (rt) IIIA NA  CT þ RT Alive (6)
18 Liu JJ et al. [6] 2011 M 47 Mandible, LN, BM IV No  CT Alive (13)
19 Guan B et al. [12] 2011 M 58 Maxillary mucosa (lt) IIE No  CT þ RT DOD (1)
20 Bagul N et al. [27] 2012 M 35 Maxillary gingiva (ant) NA No NA NA NA
21 Choi SY et al. [28] 2013 M 62 Maxillary gingiva (ant) IE No þ CT Alive (12)
22 Present case 2014 M 87 Maxillary gingiva (lt) IIE No þ S Alive (19)
ant¼ anterior; BM¼ bonemarrow; CLL¼ chronic lymphocytic leukemia; CT¼ chemotherapy; DOD¼ died of disease; lt¼ left side; NA¼ not available; RT¼ radiotherapy; rt¼
right side; S ¼ surgery.
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a lower incidence of intraoral lesions (16%) and EBV association
(46%) [2].
Lymphomas account for only 3.5% of all intraoral malignancies
[11], and our patient was HIV negative and had no appreciable
immunodeﬁcient disease. Therefore, a deﬁnitive diagnosis of the
intraoral tumor was difﬁcult. Differential diagnoses include other
B-cell lymphomas, poorly differentiated carcinoma, or amelanotic
melanoma (Table 1) [12]. In our case, biopsy revealed only a large
round cell malignant tumor with poor immunoreactivity. After
consultationwithmedical oncologists, we decided that surgery was
safer than chemotherapy because of the age of the patient. There-
fore, partial maxillectomy and radical neck dissection were per-
formed based on suspected diagnosis of poorly differentiated
carcinoma, although PBL or anaplastic plasmacytoma was possible.
Blood loss was acceptable, and the postoperative course was un-
eventful. The phenotype of the surgical specimen revealed positive
reactivity for CD38, MUM1, EBV, and CD138 and focally positive
reactivity for EMA. Therefore, the patient was ﬁnally diagnosed
with PBL. There were no tumor cells around the surgical margin.
More than 20 lymph nodes were in the neck dissection specimen,
and 6 nodes had tumor cells histologically. Because there were no
obvious lesions except for the surgically removed lesions and the
patient and his family did not consent to additional chemotherapy,
careful follow-upwas continued. Nineteenmonths after surgery, no
recurrence signs were noted.
Histologically, intraoral PBL consists of large tumor cells that
have one or several nuclei, and PBL shows a “starry-sky” appear-
ance by tingible body macrophages that have apoptotic lympho-
cytes. On the other hand, extraoral PBLs tend to have differentiated
plasmacytotic features that have rich plasma and excentric nuclei
and contain small cells [4,13]. PBL occurs commonly in the mouth;
however, it can occur in other organs [14]. Hansra et al. [13] re-
ported that intraoral PBL has a better prognosis than extraoral PBL.
Intraoral PBL is usually HIV related [15], so highly active antire-
troviral therapy for HIV may also improve the prognosis for PBL
[2,6]. On the other hand, some authors say the prognosis of PBL is
poor regardless of whether it is intraoral or extraoral, or HIV
associated or not [16].Twenty-two intraoral and HIV-negative cases of PBL have been
reportedinthe literature includingourcase(Table2) [1,4,6,12,13,17-28].
The male-to-female ratio was 16:6, and the mean age was 59.4
years. The mandible is involved slightly more often than the
maxilla, and half of the cases were EBV positive. One third of the
cases died of the disease after an average of 7 months. Treatment
was mostly chemotherapy with or without radiation therapy.
Surgery was not reported.
In our case, the patientwas older than the oldest reported case in
the literature and was at risk for anticancer agents, although a reli-
able assured chemotherapy approach has not been established.
Surgery-only therapymaybe a reasonable alternative for elderly PBL
patients, if tumors are localized and general anesthesia can be used.
Consent
Written informed consent was obtained from the patient for
publication of this case report and accompanying images. A copy of
the written consent is available for review by the Editor-in-Chief of
this journal on request.
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